Drug profile · INN
codeine phosphate
PHERAZINE VC W/ CODEINE
codeine phosphate (PHERAZINE VC W/ CODEINE) is a opioid receptors; mu/kappa/delta agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — codeine phosphate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 4
- Data quality
- 0.89
Quick answer
codeine phosphate (PHERAZINE VC W/ CODEINE) is a opioid receptors; mu/kappa/delta agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Opioid receptors; mu/kappa/delta agonist
Primary target: Opioid receptors; mu/kappa/delta
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is codeine phosphate?
codeine phosphate (PHERAZINE VC W/ CODEINE) is a opioid receptors; mu/kappa/delta agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for codeine phosphate?
PHERAZINE VC W/ CODEINE is a marketed brand name for codeine phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of codeine phosphate?
codeine phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.